false 0001526119 0001526119 2026-11-17 2026-11-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported): November 17, 2026

 

Verastem, Inc.

(Exact Name of Registrant as Specified in Charter)

 

Delaware   001-35403   27-3269467
(State or Other Jurisdiction
of Incorporation)
  (Commission
File Number)
  (IRS Employer
Identification No.)

 

117 Kendrick Street, Suite 500, Needham, MA   02494
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (781) 292-4200

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
Common stock, $0.0001 par value per share   VSTM   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

 

Chief Executive Officer Succession

 

As previously disclosed on October 14, 2026, Daniel W. Paterson notified the Board of Directors (the “Board”) of Verastem, Inc. (the “Company”) of his decision to retire as President and Chief Executive Officer of the Company, effective January 1, 2027 (the “Effective Date”). In connection with the retirement of Mr. Paterson, Michael Bailey was appointed to the position of President and Chief Executive Officer, effective as of the Effective Date (the “CEO Succession”).

 

Bailey Consulting Agreement

 

In connection with the CEO Succession described above, the Company and Mr. Bailey entered into a consulting and advisory agreement, dated November 17, 2026, and effective November 1, 2026 (the “Bailey Consulting Agreement”), pursuant to which Mr. Bailey will provide advisory services and assist the Company with the CEO Succession until December 31, 2026, unless the Bailey Consulting Agreement is earlier terminated by either party upon 30 days’ advance written notice.

 

In exchange for providing such services, Mr. Bailey will receive a monthly consulting fee of $40,000, prorated for any month of partial service and payable in cash, equity or equity-based awards, as determined by the Board. The Bailey Consulting Agreement contains certain covenants and agreements of the parties, including a perpetual confidentiality obligation.

 

The foregoing summary is qualified in its entirety by reference to the Bailey Consulting Agreement, which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated in this Item 5.02 by reference.

 

Item 9.01. Financial Statements and Exhibits

 

Exhibit No.   Description
10.1   Consulting and Advisory Agreement dated November 17, 2026, by and between Verastem, Inc. and Michael Bailey
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  VERASTEM, INC.
     
Dated: November 19, 2026 By: /s/ Daniel W. Paterson
    Daniel W. Paterson
    President and Chief Executive Officer